-
Vivia Biotech S.L., Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: 1.3 million ($1.6 million) Investor: Bioanalitica Inversiones
Published on 4/23/2012
-
Vivia Biotech S.L., Madrid, Spain Business: Cancer, Endocrine/Metabolic, Autoimmune Date completed: 4/16/12 Type: Venture financing Raised: 6 million ($7.8 million) Investor: Multiinstrument JEREMIE Fund
Published on 4/23/2012
-
ArQule Inc. (NASDAQ:ARQL), Woburn, Mass. Business: Cancer Date announced: 4/16/12 ArQule raised $7.8 million through the sale of 1.1 million shares at $7.30 to cover the overallotment from its April 11 follow-on, …
Published on 4/23/2012
-
Dyadic International Inc. (Pink:DYAI), Jupiter, Fla. Business: Genomics, Supply/Service, Biomanufacturing Date announced: 4/16/12 Dyadic extended the maturity dates of $8.4 million in outstanding promissory notes to Jan…
Published on 4/23/2012
-
Galena Biopharma Inc. (NASDAQ:GALE), Lake Oswego, Ore. Business: Cancer Date announced: 4/16/12 Galena raised $1.9 million through the sale of 1.3 million shares at $1.50 to cover the overallotment from its April 5 …
Published on 4/23/2012
-
Prima BioMed Ltd. (ASX:PRR; NASDAQ:PBMD), Sydney, Australia Business: Cancer, Infectious Date announced: 4/13/12 Prima BioMed listed its shares on NASDAQ under the ticker "PBMD" through a level II ADR program. Each ADR …
Published on 4/23/2012
-
Puma Biotechnology Inc. (OTCBB:PBYI), Los Angeles, Calif. Business: Cancer Date announced: 4/16/12 Puma said its stock began trading on the OTC Bulletin Board under the symbol "PBYI." Puma, which pursued a public …
Published on 4/23/2012
-
Telik Inc. (NASDAQ:TELK), Palo Alto, Calif. Business: Cancer Date announced: 4/17/12 Telik received notice from NASDAQ that it regained compliance with the $1 minimum bid price requirement for continued listing.
Published on 4/23/2012
-
Warnex Inc. (TSX:WNX), Laval, Quebec Business: Supply/Service Date announced: 4/16/12 Warnex said Persistence Capital Partners agreed to extend to April 19 the deadline to repay about C$960,000 ($959,328) in debentures …
Published on 4/23/2012
-
Aerocrine AB (SSE:AERO), Solna, Sweden Business: Diagnostic Date announced: 3/15/12 Type: Rights offering To be raised: Up to SEK259.9 million ($38.1 million) Shares: 28.9 million Price: SEK 9 Placement agent: Remium …
Published on 4/23/2012
-
Allon Therapeutics Inc. (TSX:NPC), Vancouver, B.C. Business: Neurology Date announced: 4/16/12 Type: Private placement of units To be raised: Up to C$10 million ($10 million) Units: 40 million Price: C$0.25 (unit) …
Published on 4/23/2012
-
AspenBio Pharma Inc. (NASDAQ:APPY), Castle Rock, Colo. Business: Veterinary, Diagnostic, Supply/Service Date announced: 4/12/12 Type: Follow-on To be raised: Up to $17.3 million Shares: TBD Price prior: $0.70 …
Published on 4/23/2012
-
biOasis Technologies Inc. (TSX-V:BTI), Vancouver, B.C. Business: Neurology, Diagnostic Date announced: 4/11/12 Type: Private placement of units To be raised: Up to C$2.1 million ($2.1 million) Units: 1.8 million Price: …
Published on 4/23/2012
-
GeneNews Ltd. (TSX:GEN), Richmond Hill, Ontario Business: Cancer, Cardiovascular, Neurology Date announced: 4/18/12 Type: Rights offering To be raised: Up to C$2.6 million ($2.6 million) Shares: 23.2 million Price: C$0.…
Published on 4/23/2012
-
Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Date announced: 4/12/12 Type: Direct public offering To be raised: $1.4 million Shares: 8.1 million Price: $0.17 Placement agent: Aegis Capital …
Published on 4/23/2012
-
Supernus Pharmaceuticals Inc., Rockville, Md. Business: Neurology, Drug delivery Date announced: 4/11/12 Type: IPO To be raised: Up to $80.8 million Shares: 5.8 million Price: $12-$14 Underwriters: Citigroup; Piper …
Published on 4/16/2012
-
Aptalis Pharma Inc., Mont-Saint-Hilaire, Quebec Business: Gastrointestinal, Pulmonary Date announced: 4/5/12 Aptalis began its cash tender offer for $195 million of its outstanding 12.75% senior notes due 2016. Aptalis …
Published on 4/16/2012
-
HemaCare Corp. (Pink:HEMA), Van Nuys, Calif. Business: Supply/Service Date announced: 4/9/12 HemaCare filed a Form 15 with the Securities Exchange Commission to voluntarily deregister its shares. The company anticipates…
Published on 4/16/2012
-
H.I.G. Capital LLC, Miami, Fla. Business: Finance Date announced: 4/10/12 H.I.G. Capital closed its H.I.G. BioVentures II L.P. fund at $268 million. The fund was oversubscribed, with an original target of $250 million. …
Published on 4/16/2012
-
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Date announced: 4/10/12 Merck's Merck Research Laboratories unit partnered with Flagship Ventures to launch and back early stage life …
Published on 4/16/2012
-
NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Date announced: 4/5/12 NeoStem raised $800,000 through the sale of 2 million units at $0.40 to cover the overallotment from its March…
Published on 4/16/2012
-
Pluromed Inc., Woburn, Mass. Business: Cardiovascular Date announced: 4/11/12 Pluromed repaid its loan of $654,228 in principal and interest from the Massachusetts Life Sciences Center. The company received the $500,000…
Published on 4/16/2012
-
Pressure BioSciences Inc. (OTCQB:PBIO), South Easton, Mass. Business: Supply/Service Date announced: 4/5/12 Pressure BioSciences was delisted from NASDAQ after it was unable to regain compliance with requirements for …
Published on 4/16/2012
-
Prolor Biotech Inc. (NYSE-A:PBTH; Tel Aviv:PBTH), Ness Ziona, Israel Business: Endocrine/Metabolic, Hematology Date announced: 4/6/12 Prolor filed a shelf registration covering the sale of up to $75 million of its …
Published on 4/16/2012
-
Pressure BioSciences Inc. (OTCQB:PBIO), South Easton, Mass. Business: Supply/Service Date announced: 4/9/12 Type: Direct public offering To be raised: $500,000 Shares: 500 Price: $1,000 Placement agent: Ladenburg …
Published on 4/16/2012